dodecyl- 3- ((1- (3,3- difluoro- 4- hydroxy- 5- (hydroxymethyl)- tetrahydrofuran- 2- yl)- 2- oxo- 1,2- dihydropyrimidin- 4- yl)carbamoyl)pyrazine- 2- carboxylate

08/01/2012 - "In in vivo studies, we evaluated the efficacy of SL-01 in nude mice bearing human cancer xenografts. "
08/01/2012 - "SL-01 also increased Bax/Bcl-2 ratio in cancer cells. "
08/01/2012 - "Our goal in this study was to evaluate the efficacy of SL-01 on the growth of human cancers with gemcitabine as control. "
08/01/2012 - "In vitro assays, SL-01 significantly inhibited the growth of cancer cells as determined by the 3-[4, 5-dimethylthiazol-2-yl]-2, 5-diphenyltetrazolium bromide (MTT) assay. "
08/01/2012 - "SL-01, an oral gemcitabine derivative, inhibited human cancer growth more potently than gemcitabine."

08/23/2013 - "We aimed to evaluate the efficacy of SL-01 on human breast cancer growth. "
08/23/2013 - "SL-01 possessed similar activity against human breast cancer growth with gemcitabine, whereas, with lower toxicity to gemcitabine. "
08/23/2013 - "SL-01, an oral derivative of gemcitabine, inhibited human breast cancer growth through induction of apoptosis."

08/01/2012 - "SL-01 effectively delayed the growth of NCI-H460 and HCT-116 without significant loss of body weight. "